CY1332A - Stable solutions of hydrogenated ergotalkaloids and heparin - Google Patents

Stable solutions of hydrogenated ergotalkaloids and heparin

Info

Publication number
CY1332A
CY1332A CY1332A CY133280A CY1332A CY 1332 A CY1332 A CY 1332A CY 1332 A CY1332 A CY 1332A CY 133280 A CY133280 A CY 133280A CY 1332 A CY1332 A CY 1332A
Authority
CY
Cyprus
Prior art keywords
ergotalkaloids
heparin
hydrogenated
stable solutions
solutions
Prior art date
Application number
CY1332A
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1332A publication Critical patent/CY1332A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY1332A 1979-11-12 1980-11-10 Stable solutions of hydrogenated ergotalkaloids and heparin CY1332A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792945636 DE2945636A1 (en) 1979-11-12 1979-11-12 STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
CY1332A true CY1332A (en) 1986-06-27

Family

ID=6085779

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1332A CY1332A (en) 1979-11-12 1980-11-10 Stable solutions of hydrogenated ergotalkaloids and heparin

Country Status (22)

Country Link
EP (1) EP0028813B1 (en)
JP (1) JPS5686116A (en)
AT (1) AT371997B (en)
AU (1) AU535357B2 (en)
BE (1) BE886008A (en)
CA (1) CA1165692A (en)
CH (1) CH650930A5 (en)
CY (1) CY1332A (en)
DE (2) DE2945636A1 (en)
DK (1) DK155144C (en)
FI (1) FI72045C (en)
GB (1) GB2062468B (en)
GR (1) GR72128B (en)
HK (1) HK40386A (en)
HU (1) HU183244B (en)
IE (1) IE50372B1 (en)
IL (1) IL61447A (en)
KE (1) KE3623A (en)
MY (1) MY8500165A (en)
PH (1) PH22800A (en)
PT (1) PT72041B (en)
ZA (1) ZA807005B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (en) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim STABLE SOLUTIONS OF MOTHER CORNAL CALOIDS
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.
DE3432661A1 (en) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger CARCINOM THERAPEUTIC
AT381232B (en) * 1985-05-13 1986-09-10 Kwizda Fa F Johann METHOD FOR PRODUCING STABLE LIQUID SOLUTIONS OF ERGOL DERIVATIVES
PL373033A1 (en) * 2002-06-20 2005-08-08 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (en) * 1977-08-06 1979-02-15 Sandoz Ag STABLE SOLUTIONS AND METHOD FOR THEIR PRODUCTION
DE2625403A1 (en) * 1976-06-05 1977-12-08 Sandoz Ag Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
DE2555481C3 (en) * 1975-12-10 1985-10-03 Sandoz-Patent-GmbH, 7850 Lörrach Production of stable drop solutions of hydrogenated ergot alkaloids
DE2945677A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Antithrombotic combination of di:hydro:ergotamine cpd. and heparin - administered using a two-chamber system syringe to avoid instability problems on prolonged storage

Also Published As

Publication number Publication date
ZA807005B (en) 1982-06-30
CH650930A5 (en) 1985-08-30
AT371997B (en) 1983-08-25
ATA550480A (en) 1983-01-15
HU183244B (en) 1984-04-28
PT72041A (en) 1980-12-01
IE50372B1 (en) 1986-04-02
DK155144B (en) 1989-02-20
DE2945636A1 (en) 1981-05-21
GB2062468A (en) 1981-05-28
IE802340L (en) 1981-05-12
FI72045B (en) 1986-12-31
IL61447A0 (en) 1980-12-31
GR72128B (en) 1983-09-16
IL61447A (en) 1983-11-30
DK477880A (en) 1981-05-13
JPS5686116A (en) 1981-07-13
PH22800A (en) 1988-12-12
AU535357B2 (en) 1984-03-15
FI803456L (en) 1981-05-13
AU6426580A (en) 1981-05-21
BE886008A (en) 1981-05-04
EP0028813A3 (en) 1982-08-25
CA1165692A (en) 1984-04-17
PT72041B (en) 1982-01-26
GB2062468B (en) 1983-08-24
DE3068719D1 (en) 1984-08-30
JPH021126B2 (en) 1990-01-10
FI72045C (en) 1987-04-13
MY8500165A (en) 1985-12-31
HK40386A (en) 1986-06-06
KE3623A (en) 1986-05-16
DK155144C (en) 1989-07-03
EP0028813A2 (en) 1981-05-20
EP0028813B1 (en) 1984-07-25

Similar Documents

Publication Publication Date Title
GB2053252B (en) Polyoxyalkylenediamides and lubricants containing same
PH18683A (en) Novel 4-aroylimidazol-2-ones and their use
JPS55100368A (en) Nnbenzylimidazole and its manufacture and use
JPS5598114A (en) Antiobesity and triglyceride reducing agent
JPS55136477A (en) Contact unit and method of manufacturing same
JPS56124651A (en) Lockerrhousing and lockerrcover
JPS5616522A (en) Manufacture of polycarbonate* polycarbonate thereby and its use
JPS5640680A (en) 33methyleneflavanone and 33methylenechromanone and their use
JPS5617245A (en) Long structure and its manufacture
AU538238B2 (en) Combination of hollow member and baching member
JPS5646863A (en) Manufacture of 22alkyll and 22aryll trimethylphenol
JPS55154994A (en) Amtibiotic aa6888c and aa6888x
JPS5495599A (en) Manufacture of 3 iodoo and 3 bromorifamycin s
GB2062468B (en) Stable solutions of hydrogenated ergotalkaloids and heparin
AU540280B2 (en) Solutions of bromoxyail and ioxyail
EG15299A (en) Insectisidally active acyl ureas and their manufacture and use
JPS5444672A (en) Manufacture of benzotriazole and benzotriazoleennoxide
JPS55149241A (en) Manufacture of arylmonourethane and arylpolyurethane
JPS5461120A (en) Manufacture of alkylthiosulfate and alkylidenethiosulfate
IL61039A0 (en) Preparation of 1-azolyl-1-phenoxy-alkan-2-ones and 1-azolyl-1-halo-alkan-2-ones used therefor
JPS5433523A (en) Cementtbased structure and method of making same
JPS5543100A (en) Manufacture of ccsubstituted pyridine and*or hydrogenated ccsubstituted pyridine
JPS5461137A (en) Manufacture of benzoylhalide and halosulfonylbenzoylhalide
JPS5622754A (en) Nnmmtrifluoromethylphenylanthranilate of ooalkoxycarbonylphenyl* its manufacture and its use
JPS55161859A (en) Manufacture of benzoxanthenee and benzothioxantheneedye